Spain Exosomes Market Size & Outlook, 2023-2030

The exosomes market in Spain is expected to reach a projected revenue of US$ 6.9 million by 2030. A compound annual growth rate of 24.1% is expected of Spain exosomes market from 2024 to 2030.
Revenue, 2023 (US$M)
$1.5
Forecast, 2030 (US$M)
$6.9
CAGR, 2024 - 2030
24.4%
Report Coverage
Spain

Spain exosomes market highlights

  • The Spain exosomes market generated a revenue of USD 1.5 million in 2023 and is expected to reach USD 8.9 million by 2030.
  • The Spain market is expected to grow at a CAGR of 28.6% from 2024 to 2030.
  • In terms of segment, kits & reagents was the largest revenue generating product in 2023.
  • Kits & Reagents is the most lucrative product segment registering the fastest growth during the forecast period.


Exosomes market data book summary

Market revenue in 2023USD 1.5 million
Market revenue in 2030USD 8.9 million
Growth rate28.6% (CAGR from 2023 to 2030)
Largest segmentKits & reagents
Fastest growing segmentKits & Reagents
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationKits & Reagents, Instruments, Services
Key market players worldwideDanaher Corp, Hologic Inc, FUJIFILM Holdings Corp, Lonza Group Ltd, Miltenyi Biotec, Bio-Techne Corp, Qiagen NV, Thermo Fisher Scientific Inc, Abcam PLC, RoosterBio


Other key industry trends

  • In terms of revenue, Spain accounted for 1.1% of the global exosomes market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Europe, Germany exosomes market is projected to lead the regional market in terms of revenue in 2030.
  • UK is the fastest growing regional market in Europe and is projected to reach USD 54.7 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Exosomes Market Companies

Name Profile # Employees HQ Website

Spain exosomes market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to exosomes market will help companies and investors design strategic landscapes.


Kits & reagents was the largest segment with a revenue share of 46.67% in 2023. Horizon Databook has segmented the Spain exosomes market based on kits & reagents, instruments, services covering the revenue growth of each sub-segment from 2018 to 2030.


Increase in the number of research activities for exploring the potential of exosomes across various applications is expected to boost the exosomes market growth in the country. For instance, a research study was performed at Universidad Autónoma de Madrid in 2014, to determine the potential of exosomes to become a key target in the cardio-renal syndrome.

The study was performed across 23 hospitals in the country wherein researchers from the Barcelona Institute for Global Health (ISGlobal) and the Autonomous University of Madrid, Hospital la Princesa were employed.

The study concluded that stroke as well as ischaemic heart disease accounted for 22% of the total mortality rate in 2016; and ischaemic heart disease accounted for maximum deaths among other factors. Thus, research focused on utilization of exosomes in the cardiovascular disease application is expected to offer significant momentum to the Spain exosomes market.

Reasons to subscribe to Spain exosomes market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Spain exosomes market databook

  • Our clientele includes a mix of exosomes market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Spain exosomes market , including forecasts for subscribers. This country databook contains high-level insights into Spain exosomes market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Spain exosomes market size, by product, 2018-2030 (US$M)

Spain Exosomes Market Outlook Share, 2023 & 2030 (US$M)

Spain exosomes market size, by product, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more